Accrol Group Holdings Investor Presentation 2023

Accrol Group Holdings (LON:ACRL) CEO Gareth Jenkins talks through the 2023 Investor Presentation with results for the six months ended 31 October 2022.

Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable wet wipes.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Accrol Group

More articles like this

Accrol Group

What are the latest technology trends in manufacturing?

We asked the FactoryTech 50 and judging panel to describe a particular trend they have noticed in manufacturing technology in the last year. Judge Kevin Smith (below) is lead technology advisor at Made Smarter UK, which has engaged

Accrol Group

UK Manufacturing industry shows growth and recovery in March

The UK’s manufacturing industry has returned to growth and is showing “tentative signs of recovery”, according to a closely-watched survey. Both output and new orders increased in March, while business optimism also hit an 11-month high,

Accrol Group

British manufacturing sees surge in sales and job creation

British manufacturing is witnessing a Brexit boost as sales rocket in the EU, Middle East and Far East, and the lifeblood of the UK economy flows once more. Major players in automotive, aerospace, construction, electrification, and

Accrol Group

Accrol Group Holdings Results Presentation 2024 (VIDEO)

Accrol Group Holdings (LON:ACRL) CEO Gareth Jenkins and CFO Chris Welsh present its latest results and company overview. Accrol Group Holdings is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towels, facial tissue and biodegradable

Accrol Group

Greenarc partnered with Accrol to install onsite EV chargers

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes. The UK soft tissue market is worth £1.6bn with private label products comprising